December 27, 2018
Sales reps at Shionogi were revving up their GP visits for the company’s novel single-dose influenza drug Xofluza (baloxavir marboxil) in October before the influenza season went into full swing, market research firm Anterio’s “Impact Track” survey showed. The Impact...read more